Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy.
Saved in:
| Title: | Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy. |
|---|---|
| Authors: | Kopylov U; Tel Aviv, Israel., Hanzel J; Ljubljana, Slovenia., Liefferinckx C; Brussels, Belgium., De Marco D; Montreal, Canada., Imperatore N; Naples, Italy., Plevris N; Edinburgh, UK., Baston-Rey I; Santiago de Compostela, Spain., Harris RJ; Southampton, UK., Truyens M; Ghent, Belgium., Domislovic V; Zagreb, Croatia., Vavricka S; Zurich, Switzerland., Biemans V; Maastricht, The Netherlands.; Nijmegen, The Netherlands., Myers S; Hull, UK., Sebastian S; Hull, UK., Ben-Horin S; Tel Aviv, Israel., González Lama Y; Madrid, Spain., Gilletta C; Toulouse, France., Ariella BS; Jerusalem, Israel., Zelinkova Z; Bratislava, Slovakia., Weisshof R; Haifa, Israel., Storan D; Dublin, Ireland., Zittan E; Afula, Israel., Farkas K; Szeged, Hungary., Molnar T; Szeged, Hungary., Franchimont D; Brussels, Belgium., Cremer A; Brussels, Belgium., Afif W; Montreal, Canada., Castiglione F; Naples, Italy., Lees C; Edinburgh, UK., Barreiro-de Acosta M; Santiago de Compostela, Spain., Lobaton T; Ghent, Belgium., Doherty G; Dublin, Ireland., Krznaric Z; Haifa, Israel., Pierik M; Maastricht, The Netherlands., Hoentjen F; Nijmegen, The Netherlands., Drobne D; Ljubljana, Slovenia. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Jul; Vol. 52 (1), pp. 135-142. Date of Electronic Publication: 2020 May 15. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!